Achmea Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.9M Sell
115,829
-15,448
-12% -$1.81M 0.37% 67
2026
Q1
$15.8M Sell
131,277
-48,034
-27% -$5.55M 0.42% 60
2025
Q4
$18.9M Sell
179,311
-438
-0.2% -$41.1K 0.48% 52
2025
Q3
$15.1M Buy
179,749
+4,156
+2% +$342K 0.19% 140
2025
Q2
$13.9M Sell
175,593
-7,220
-4% -$574K 0.18% 147
2025
Q1
$16.4M Buy
182,813
+14,980
+9% +$1.4M 0.24% 122
2024
Q4
$16.7M Sell
167,833
-24,270
-13% -$2.5M 0.27% 97
2024
Q3
$21.8M Buy
192,103
+15,043
+8% +$1.79M 0.36% 69
2024
Q2
$21.9M Buy
177,060
+12,249
+7% +$1.58M 0.39% 61
2024
Q1
$21.7M Sell
164,811
-203,288
-55% -$25.1M 0.41% 62
2023
Q4
$40.1M Sell
368,099
-47,998
-12% -$4.98M 0.83% 23
2023
Q3
$42.8M Buy
416,097
+1,804
+0.4% +$194K 0.93% 17
2023
Q2
$47.8M Buy
414,293
+60,681
+17% +$6.89M 1.01% 15
2023
Q1
$37.6M Buy
353,612
+19,857
+6% +$2.14M 1.09% 13
2022
Q4
$34.7M Buy
333,755
+430
+0.1% +$44K 1.16% 14
2022
Q3
$28.7M Buy
333,325
+58,447
+21% +$5.22M 1.02% 15
2022
Q2
$25.1M Buy
274,878
+29,730
+12% +$2.64M 0.81% 22
2022
Q1
$20.1M Buy
+245,148
New +$19.3M 0.52% 33
2021
Q4
Sell
-237,443
Closed -$17.8M 424
2021
Q3
$17.8M Sell
237,443
-24,984
-10% -$1.9M 0.54% 34
2021
Q2
$20.4M Sell
262,427
-81,889
-24% -$6.09M 0.7% 21
2021
Q1
$25.3M Buy
344,316
+14,596
+4% +$1.08M 0.88% 15
2020
Q4
$25.7M Buy
329,720
+32,812
+11% +$2.51M 0.93% 15
2020
Q3
$23.5M Sell
296,908
-776,554
-72% -$60.8M 0.98% 15
2020
Q2
$79.2M Sell
1,073,462
-177,935
-14% -$13.4M 2.68% 7
2020
Q1
$91.9M Buy
1,251,397
+822,576
+192% +$64.6M 4.21% 2
2019
Q4
$37.2M Sell
428,821
-2,609
-0.6% -$214K 1.43% 10
2019
Q3
$34.7M Sell
431,430
-15,256
-3% -$1.22M 1.37% 8
2019
Q2
$35.7M Buy
446,686
+3,616
+0.8% +$277K 1.37% 11
2019
Q1
$35.2M Buy
443,070
+5,449
+1% +$408K 1.46% 13
2018
Q4
$31.9M Buy
437,621
+159,086
+57% +$11.2M 1.47% 12
2018
Q3
$18.9M Sell
278,535
-25,012
-8% -$1.59M 0.71% 27
2018
Q2
$17.6M Sell
303,547
-18,108
-6% -$1.02M 0.61% 31
2018
Q1
$16.7M Sell
321,655
-167,723
-34% -$9.06M 0.56% 40
2017
Q4
$26.3M Buy
489,378
+163,334
+50% +$9.06M 0.89% 23
2017
Q3
$19.9M Sell
326,044
-24,697
-7% -$1.5M 1.13% 13
2017
Q2
$21.4M Sell
350,741
-117,080
-25% -$7.13M 1.29% 8
2017
Q1
$28.4M Buy
+467,821
New +$28.4M 1.33% 12

Other funds holding MRK

Achmea Investment Management's MRK Position: Q2 2026 in Review

Achmea Investment Management reduced its Merck (MRK) stake by 12% in Q2 2026, selling an estimated $1.81M and leaving 115,829 shares worth $14.9M. The position accounts for 0.37% of the portfolio, ranked #67.

Achmea Investment Management first reported a position in MRK in Q1 2017 and has held it in 37 quarters since. The position peaked at $91.9M in Q1 2020. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Achmea Investment Management held 115,829 shares of Merck worth $14.9M as of Q2 2026.
  • Achmea Investment Management sold 15,448 Merck shares in Q2 2026, an estimated $1.81M.
  • Merck made up 0.37% of Achmea Investment Management's portfolio in Q2 2026, its #67 holding.
  • Achmea Investment Management first reported a position in Merck in Q1 2017 and has held it in 37 quarters since.
  • Achmea Investment Management's Merck position peaked at $91.9M in Q1 2020.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Achmea Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.